Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Cervical Cancer, October 2017

Free Subscription


Abstracts

Retrieve all available abstracts of the following 222 articles:
HTML format


 

Single Articles

  1. DAVIDSON KT, Zhu Z, Bai Q, Xiao H, et al
    Blueberry as a Potential Radiosensitizer for Treating Cervical Cancer.
    Pathol Oncol Res. 2017 Sep 30. doi: 10.1007/s12253-017-0319.
    Abstract    

    Abstract available

  2. HWEISSA NA, Su TT
    Awareness of cervical cancer and socio-demographic variations among women in Libya: An exploratory study in Az-Zawiya city.
    Eur J Cancer Care (Engl). 2017 Sep 27. doi: 10.1111/ecc.12750.
    Abstract    

    Abstract available

  3. FENG H, Hu Y, Jin P, Meng X, et al
    Intensity-modulated radiotherapy combined with iodine-125 seed implantation in non-central recurrence of cervical cancer: A case report and literature review.
    Oncol Lett. 2017;14:4085-4091.
    Abstract    

    Abstract available

  4. LEINONEN MK, Campbell S, Ursin G, Trope A, et al
    Barriers to cervical cancer screening faced by immigrants: a registry-based study of 1.4 million women in Norway.
    Eur J Public Health. 2017;27:873-879.
    Abstract    

    Abstract available

  5. RUDD P, Gorman D, Meja S, Mtonga P, et al
    Cervical cancer in southern Malawi: A prospective analysis of presentation, management, and outcomes.
    Malawi Med J. 2017;29:124-129.
    Abstract    

    Abstract available

  6. POTIKANOND S, Sookkhee S, Na Takuathung M, Mungkornasawakul P, et al
    Kaempferia parviflora Extract Exhibits Anti-cancer Activity against HeLa Cervical Cancer Cells.
    Front Pharmacol. 2017;8:630.
    Abstract    

    Abstract available

  7. BURDAN F, Mocarska A, Klepacz R, Walocha J, et al
    Place of residence does not significantly influence radiological morphology of cervical cancer.
    Ann Agric Environ Med. 2017;24:527-531.
    Abstract    

    Abstract available

  8. KYCLER W, Kubiak A, Rzymski P, Wilczak M, et al
    Impact of selected environmental factors on attendance in the Breast and Cervical Cancer Early Detection Programme in the Wielkopolska Province of Poland during 2007-2012.
    Ann Agric Environ Med. 2017;24:467-471.
    Abstract    

    Abstract available

  9. LIANG SC, Wang ZQ, Wang JL
    [Clinical analysis of 76 cases of sentinel lymph node detection in cervical cancer and endometrial cancer].
    Zhonghua Fu Chan Ke Za Zhi. 2017;52:605-611.
    Abstract    

    Abstract available

  10. WU RF, Du H
    [Development of model based on self-sampling HPV testing for cervical cancer screening].
    Zhonghua Fu Chan Ke Za Zhi. 2017;52:582-585.
    Abstract    



  11. MAZUL J, Perkins RB
    Stage IV Cervical Cancer in a Patient Compliant With Current Management Guidelines for Abnormal Cytology: A Case Report.
    J Low Genit Tract Dis. 2017;21:e40-e41.
    Abstract    



  12. SIEGLER E, Goldberg Y, Baruch-Finkel T, Shaked-Mishan P, et al
    Positive Correlation Between Clearance of High-Risk Human Papillomavirus and Lack of Residual Disease After Loop Excision of the Transformation Zone in Early Stage Cervical Cancer.
    J Low Genit Tract Dis. 2017;21:294-298.
    Abstract    

    Abstract available

  13. MACNAB WS, Holdsworth TF, Lindsay R, Shanbhag S, et al
    The Current Burden of Follow-up of Stage 1A1 Cervical Cancer.
    J Low Genit Tract Dis. 2017;21:268-271.
    Abstract    

    Abstract available

  14. WENTZENSEN N, Massad LS, Mayeaux EJ Jr, Khan MJ, et al
    Evidence-Based Consensus Recommendations for Colposcopy Practice for Cervical Cancer Prevention in the United States.
    J Low Genit Tract Dis. 2017;21:216-222.
    Abstract    

    Abstract available

  15. MONTEIRO PB, Monteiro Filho MP, de Figueiredo JT, Saintrain MVL, et al
    Cytology-Based Screening During Antenatal Care as a Method for Preventing Cervical Cancer
    Asian Pac J Cancer Prev. 2017;18:2513-2518.
    Abstract    

    Abstract available

  16. TAPERA R, Manyala E, Erick P, Maswabi TM, et al
    Knowledge and Attitudes towards Cervical Cancer Screening amongst University of Botswana Female Students
    Asian Pac J Cancer Prev. 2017;18:2445-2450.
    Abstract    

    Abstract available

  17. FRANCO DN, Tomaz ACV, Gravena AAF, Pelloso SM, et al
    Screening Cervical Cancer by the Pap Test - Relevance of Age Ranges Recommended by the Brazilian Programme for Prevention and Control
    Asian Pac J Cancer Prev. 2017;18:2431-2435.
    Abstract    

    Abstract available

  18. LIU H, Pei G, Song M, Dai S, et al
    Influence of hsa-miR-6727-5p on the proliferation, apoptosis, invasion and migration of Caski, Hela and SiHa cervical cancer cells.
    J BUON. 2017;22:973-978.
    Abstract    

    Abstract available

  19. LEI H, Gui D, He Y
    Short- and long-term outcomes of laparoscopic radical hysterectomy for obese patients with cervical cancer.
    J BUON. 2017;22:958-965.
    Abstract    

    Abstract available

  20. KANG H, Padilla L, Hasan Y, Al-Hallaq H, et al
    Automated calculation of point A coordinates for CT-based high-dose-rate brachytherapy of cervical cancer.
    J Contemp Brachytherapy. 2017;9:354-358.
    Abstract    

    Abstract available

  21. YING CHUA GW, Foo YW, Tay GH, Harn Tan DB, et al
    Assessing dose contribution to pelvic lymph nodes in intracavitary brachytherapy for cervical cancer.
    J Contemp Brachytherapy. 2017;9:345-353.
    Abstract    

    Abstract available

  22. MORA-GARCIA ML, Avila-Ibarra LR, Garcia-Rocha R, Weiss-Steider B, et al
    Cervical cancer cells suppress effector functions of cytotoxic T cells through the adenosinergic pathway.
    Cell Immunol. 2017 Sep 7. pii: S0008-8749(17)30136.
    Abstract    

    Abstract available

  23. TOH ZQ, Licciardi PV, Russell FM, Garland SM, et al
    Cervical Cancer Prevention Through HPV Vaccination in Low- and Middle-Income Countries in Asia
    Asian Pac J Cancer Prev. 2017;18:2339-2343.
    Abstract    

    Abstract available

  24. DE CAMPOS RP, Schultz IC, de Andrade Mello P, Davies S, et al
    Cervical cancer stem like cells: Systematic review and identification of reference genes for gene expression.
    Cell Biol Int. 2017 Sep 26. doi: 10.1002/cbin.10878.
    Abstract    

    Abstract available

  25. ZHOU W, Huang C, Zou X, Lu Y, et al
    Erratum to: Exhaled breath online measurement for cervical cancer patients and healthy subjects by proton transfer reaction mass spectrometry.
    Anal Bioanal Chem. 2017 Sep 25. doi: 10.1007/s00216-017-0631.
    Abstract    



  26. LAVIGNE AW, Triedman SA, Randall TC, Trimble EL, et al
    Cervical cancer in low and middle income countries: Addressing barriers to radiotherapy delivery.
    Gynecol Oncol Rep. 2017;22:16-20.
    Abstract    

    Abstract available

  27. OCHOMO EO, Atieli H, Gumo S, Ouma C, et al
    Assessment of community health volunteers' knowledge on cervical cancer in Kadibo Division, Kisumu County: a cross sectional survey.
    BMC Health Serv Res. 2017;17:675.
    Abstract    

    Abstract available

  28. SO WKW, Kwong ANL, Chen JMT, Chan JCY, et al
    A Theory-Based and Culturally Aligned Training Program on Breast and Cervical Cancer Prevention for South Asian Community Health Workers: A Feasibility Study.
    Cancer Nurs. 2017 Sep 23. doi: 10.1097/NCC.0000000000000543.
    Abstract    

    Abstract available

  29. LEUNG TH, Tang HW, Siu MK, Chan DW, et al
    HPV-E6 protein enriches the CD55(+) population in cervical cancer cells promoting radio-resistance and cancer aggressiveness.
    J Pathol. 2017 Sep 25. doi: 10.1002/path.4991.
    Abstract    

    Abstract available

  30. LEE KM, Lee K, Choi YK, Choi YJ, et al
    SH003induced G1 phase cell cycle arrest induces apoptosis in HeLa cervical cancer cells.
    Mol Med Rep. 2017 Sep 25. doi: 10.3892/mmr.2017.7597.
    Abstract    

    Abstract available

  31. ZHANG F, Ren CC, Liu L, Chen YN, et al
    SHH Gene Silencing Suppresses Epithelial-Mesenchymal Transition, Proliferation, Invasion and Migration of Cervical Cancer Cells by Repressing the Hedgehog Signaling Pathway.
    J Cell Biochem. 2017 Sep 23. doi: 10.1002/jcb.26414.
    Abstract    

    Abstract available

  32. SAFIGHOLI H, Han DY, Mashouf S, Soliman A, et al
    Direction Modulated Brachytherapy (DMBT) for Treatment of Cervical Cancer: A Planning Study with 192Ir, 60Co, and 169Yb HDR Sources.
    Med Phys. 2017 Sep 22. doi: 10.1002/mp.12598.
    Abstract    

    Abstract available

  33. LOFTERS AK, Vahabi M, Kim E, Ellison L, et al
    Cervical Cancer Screening among Women from Muslim-Majority Countries in Ontario, Canada.
    Cancer Epidemiol Biomarkers Prev. 2017.
    Abstract    

    Abstract available

  34. CHEN Z, Shi Y, Wang S, Lu Q, et al
    Meta-analysis showing that early response to neoadjuvant chemotherapy predicts better survival among cervical cancer patients.
    Oncotarget. 2017;8:59609-59617.
    Abstract    

    Abstract available

  35. CAROW K, Golitz M, Wolf M, Hafner N, et al
    Viral-Cellular DNA Junctions as Molecular Markers for Assessing Intra-Tumor Heterogeneity in Cervical Cancer and for the Detection of Circulating Tumor DNA.
    Int J Mol Sci. 2017;18.
    Abstract    

    Abstract available

  36. ZHU Y, Zhang GN, Zhang RB, Shi Y, et al
    Sonographic image of cervix epithelioid trophoblastic tumor coexisting with mucinous adenocarcinoma in a postmenopausal woman: A case report.
    Medicine (Baltimore). 2017;96:e7731.
    Abstract    

    Abstract available

  37. MIRABELLO L, Yeager M, Yu K, Clifford GM, et al
    HPV16 E7 Genetic Conservation Is Critical to Carcinogenesis.
    Cell. 2017;170:1164-1174.
    Abstract    

    Abstract available

  38. LOWY DR, Schiller JT
    Preventing Cancer and Other Diseases Caused by Human Papillomavirus Infection: 2017 Lasker-DeBakey Clinical Research Award.
    JAMA. 2017;318:901-902.
    Abstract    



  39. SZENTIRMAY Z, Veleczki Z, Kasler M
    [Human papillomavirus associated cervix uteri morbidity in Hungary: epidemiology and correlation with the HPV types and the simultaneous cytological diagnosis].
    Orv Hetil. 2017;158:1213-1221.
    Abstract    

    Abstract available

  40. PADILHA CML, Araujo MLC Junior, Souza SAL
    Cytopathologic evaluation of patients submitted to radiotherapy for uterine cervix cancer.
    Rev Assoc Med Bras (1992). 2017;63:379-385.
    Abstract    

    Abstract available

  41. TYSZKA-CZOCHARA M, Bukowska-Strakova K, Majka M
    Metformin and caffeic acid regulate metabolic reprogramming in human cervical carcinoma SiHa/HTB-35 cells and augment anticancer activity of Cisplatin via cell cycle regulation.
    Food Chem Toxicol. 2017;106.
    Abstract    

    Abstract available

  42. POLEK C, Hardie T
    Changing HPV vaccination rates in bisexual and lesbian women.
    J Am Assoc Nurse Pract. 2017;29:333-339.
    Abstract    

    Abstract available

  43. ZHANG Y, Ren YJ, Guo LC, Ji C, et al
    Nucleus accumbens-associated protein-1 promotes glycolysis and survival of hypoxic tumor cells via the HDAC4-HIF-1alpha axis.
    Oncogene. 2017;36:4171-4181.
    Abstract    

    Abstract available

  44. RIGGIO AI, Blyth K
    The enigmatic role of RUNX1 in female-related cancers - current knowledge & future perspectives.
    FEBS J. 2017;284:2345-2362.
    Abstract    

    Abstract available

  45. YAO YL, Tian QF, Cheng B, Cheng YF, et al
    Human papillomavirus (HPV) E6/E7 mRNA detection in cervical exfoliated cells: a potential triage for HPV-positive women.
    J Zhejiang Univ Sci B. 2017;18:256-262.
    Abstract    

    Abstract available

  46. YE J, Cheng B, Cheng YF, Yao YL, et al
    Prognostic value of human papillomavirus 16/18 genotyping in low-grade cervical lesions preceded by mildly abnormal cytology.
    J Zhejiang Univ Sci B. 2017;18:249-255.
    Abstract    

    Abstract available

  47. HONG SY
    DNA damage response is hijacked by human papillomaviruses to complete their life cycle.
    J Zhejiang Univ Sci B. 2017;18:215-232.
    Abstract    

    Abstract available

  48. ARNESEN MR, Hellebust TP, Malinen E
    Impact of dose escalation and adaptive radiotherapy for cervical cancers on tumour shrinkage-a modelling study.
    Phys Med Biol. 2017;62:N107-N119.
    Abstract    

    Abstract available

  49. WEN F, Xu JZ, Wang XR
    Increased expression of miR-15b is associated with clinicopathological features and poor prognosis in cervical carcinoma.
    Arch Gynecol Obstet. 2017;295:743-749.
    Abstract    

    Abstract available

  50. ZHANG X, Jia L, Tao X, Ding J, et al
    Intraoperative nerve staining in nerve-sparing radical hysterectomy: a pilot study.
    Arch Gynecol Obstet. 2017;295:737-741.
    Abstract    

    Abstract available

  51. CHIKAZAWA K, Netsu S, Akashi K, Suzuki Y, et al
    Increase in the cervical length after the loop electrosurgical excision procedure for grade III cervical intraepithelial neoplasia.
    J Obstet Gynaecol. 2017;37:78-81.
    Abstract    

    Abstract available

  52. ARVIZO C, Mahdi H
    Disparities in cervical cancer in African American women: What primary care physicians can do.
    Cleve Clin J Med. 2017;84:788-794.
    Abstract    



  53. MISRA-HEBERT AD
    Cervical cancer in African American women: Optimizing prevention to reduce disparities.
    Cleve Clin J Med. 2017;84:795-796.
    Abstract    



  54. MOSTAFA MG, Queen ZJ, Cherry N
    Histopathology of Cervical Cancer and Arsenic Concentration in Well Water: An Ecological Analysis.
    Int J Environ Res Public Health. 2017;14.
    Abstract    

    Abstract available

  55. CHEN S, Tao M, Zhao L, Zhang X, et al
    The association between diabetes/hyperglycemia and the prognosis of cervical cancer patients: A systematic review and meta-analysis.
    Medicine (Baltimore). 2017;96:e7981.
    Abstract    

    Abstract available

  56. FIRMINO-MACHADO J, Mendes R, Moreira A, Lunet N, et al
    Stepwise strategy to improve Cervical Cancer Screening Adherence (SCAN-CC): automated text messages, phone calls and face-to-face interviews: protocol of a population-based randomised controlled trial.
    BMJ Open. 2017;7:e017730.
    Abstract    

    Abstract available

  57. HSIN MC, Hsieh YH, Wang PH, Ko JL, et al
    Hispolon suppresses metastasis via autophagic degradation of cathepsin S in cervical cancer cells.
    Cell Death Dis. 2017;8:e3089.
    Abstract    

    Abstract available

  58. KUGUYO O, Matimba A, Tsikai N, Magwali T, et al
    Cervical cancer in Zimbabwe: a situation analysis.
    Pan Afr Med J. 2017;27:215.
    Abstract    

    Abstract available

  59. ZHANG J, Gao Y
    CCAT-1 promotes proliferation and inhibits apoptosis of cervical cancer cells via the Wnt signaling pathway.
    Oncotarget. 2017;8:68059-68070.
    Abstract    

    Abstract available

  60. CUI X, Jing X, Wu X
    The prognostic value of long non coding RNAs in cervical cancer: A meta-analysis.
    Oncotarget. 2017;8:62470-62477.
    Abstract    

    Abstract available

  61. CHEN RJ, Shun CT, Yen ML, Chou CH, et al
    Methyltransferase G9a promotes cervical cancer angiogenesis and decreases patient survival.
    Oncotarget. 2017;8:62081-62098.
    Abstract    

    Abstract available

  62. SHIN S, Im HJ, Kwon YJ, Ye DJ, et al
    Human steroid sulfatase induces Wnt/beta-catenin signaling and epithelial-mesenchymal transition by upregulating Twist1 and HIF-1alpha in human prostate and cervical cancer cells.
    Oncotarget. 2017;8:61604-61617.
    Abstract    

    Abstract available

  63. XIE J, Zhang W, Zhang J, Lv QY, et al
    Downregulation of SASH1 correlates with poor prognosis in cervical cancer.
    Eur Rev Med Pharmacol Sci. 2017;21:3781-3786.
    Abstract    

    Abstract available

  64. LIU Y, Tian LB, Yang HY, Zhang HP, et al
    Effects of estradiol and progesterone on the growth of HeLa cervical cancer cells.
    Eur Rev Med Pharmacol Sci. 2017;21:3959-3965.
    Abstract    

    Abstract available

  65. MARTINS J, Vaz AF, Grion RC, Esteves SCB, et al
    Factors associated with changes in vaginal length and diameter during pelvic radiotherapy for cervical cancer.
    Arch Gynecol Obstet. 2017 Oct 3. doi: 10.1007/s00404-017-4553.
    Abstract    

    Abstract available

  66. ZHAO D, Qiu H, Zhang H, Hong L, et al
    Treatment results of adjuvant pelvic radiotherapy after radical hysterectomy for low-risk Stage IB1-IIA cervical cancer.
    Jpn J Clin Oncol. 2017 Sep 8:1-8. doi: 10.1093.
    Abstract    

    Abstract available

  67. CAMPOS NG, Tsu V, Jeronimo J, Njama-Meya D, et al
    Cost-effectiveness of an HPV self-collection campaign in Uganda: comparing models for delivery of cervical cancer screening in a low-income setting.
    Health Policy Plan. 2017 Aug 23. doi: 10.1093.
    Abstract    



  68. WANG H, Zhao Y, Chen M, Cui J, et al
    Identification of Novel Long Non-coding and Circular RNAs in Human Papillomavirus-Mediated Cervical Cancer.
    Front Microbiol. 2017;8:1720.
    Abstract    

    Abstract available

  69. LIN M, Xue XY, Liang SZ, Li YX, et al
    MiR-187 overexpression inhibits cervical cancer progression by targeting HPV16 E6.
    Oncotarget. 2017;8:62914-62926.
    Abstract    

    Abstract available

  70. TRON L, Lert F, Spire B, Dray-Spira R, et al
    Levels and determinants of breast and cervical cancer screening uptake in HIV-infected women compared with the general population in France.
    HIV Med. 2017;18:181-195.
    Abstract    

    Abstract available

  71. RYSER MD, Rositch A, Gravitt PE
    Modeling of US Human Papillomavirus (HPV) Seroprevalence by Age and Sexual Behavior Indicates an Increasing Trend of HPV Infection Following the Sexual Revolution.
    J Infect Dis. 2017;216:604-611.
    Abstract    

    Abstract available

  72. HALLE MK, Ojesina AI, Engerud H, Woie K, et al
    Clinicopathologic and molecular markers in cervical carcinoma; a prospective cohort study.
    Am J Obstet Gynecol. 2017 Jun 6. pii: S0002-9378(17)30732.
    Abstract    

    Abstract available

  73. BUCHANAN T, Pierce JY, Graybill W, Kohler M, et al
    Why do we continue to overtreat stage Ia carcinoma of the cervix?
    Am J Obstet Gynecol. 2017;217:413-417.
    Abstract    

    Abstract available

  74. FERRARI M, Travaini LL, Ciardo D, Garibaldi C, et al
    Interim 18FDG PET/CT during radiochemotherapy in the management of pelvic malignancies: A systematic review.
    Crit Rev Oncol Hematol. 2017;113:28-42.
    Abstract    

    Abstract available

  75. LAYFIELD LJ, Hammer RD, Frazier SR, Esebua M, et al
    Impact of Consensus Conference Review on Diagnostic Disagreements in the Evaluation of Cervical Biopsy Specimens.
    Am J Clin Pathol. 2017;147:473-476.
    Abstract    

    Abstract available

  76. CHUERY ACS, Silva IDCGD, Ribalta JCL, Speck NMG, et al
    Association between the p53 arginine/arginine homozygous genotype at codon 72 and human papillomavirus E6/E7 mRNA expression.
    Braz J Infect Dis. 2017;21:248-254.
    Abstract    

    Abstract available

  77. GUANG Y, Luo Y, Zhang Y, Zhang M, et al
    Efficacy and safety of percutaneous ultrasound guided radiofrequency ablation for treating cervical metastatic lymph nodes from papillary thyroid carcinoma.
    J Cancer Res Clin Oncol. 2017;143:1555-1562.
    Abstract    

    Abstract available

  78. TAO X, Zheng B, Yin F, Zeng Z, et al
    Polymerase Chain Reaction Human Papillomavirus (HPV) Detection and HPV Genotyping in Invasive Cervical Cancers With Prior Negative HC2 Test Results.
    Am J Clin Pathol. 2017;147:477-483.
    Abstract    

    Abstract available

  79. MENG J, Zhu L, Zhu L, Ge Y, et al
    Histogram analysis of apparent diffusion coefficient for monitoring early response in patients with advanced cervical cancers undergoing concurrent chemo-radiotherapy.
    Acta Radiol. 2017;58:1400-1408.
    Abstract    

    Abstract available

  80. MA Q, Zhao M, Wei X, Zhao J, et al
    Expressions of Immune Negative Regulator FoxP3+Treg and PD-L1 Protein in the Immune Microenvironment of Cervical Lesion.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2017;39:128-132.
    Abstract    

    Abstract available

  81. DELORY T, Ngo-Giang-Huong N, Rangdaeng S, Chotivanich N, et al
    Human Papillomavirus infection and cervical lesions in HIV infected women on antiretroviral treatment in Thailand.
    J Infect. 2017;74:501-511.
    Abstract    

    Abstract available

  82. QI YX, Liu K, Yin J, Li L, et al
    Evaluation of short- and long-term efficacy of chemoradiotherapy for advanced cervical cancer using HSP70 protein combined with multimodal MRI.
    J Cell Biochem. 2017 Oct 11. doi: 10.1002/jcb.26424.
    Abstract    

    Abstract available

  83. SHI Y, Wang W, Yang B, Tian H, et al
    ATF1 and RAS in exosomes are potential clinical diagnostic markers for cervical cancer.
    Cell Biochem Funct. 2017 Oct 10. doi: 10.1002/cbf.3307.
    Abstract    

    Abstract available

  84. SARWATH H, Bansal D, Husain NE, Mohamed M, et al
    Introduction of p16INK4a as a surrogate biomarker for HPV in women with invasive cervical cancer in Sudan.
    Infect Agent Cancer. 2017;12:50.
    Abstract    

    Abstract available

  85. CHEN L, Qiang P, Shao Y
    Research on the correlation between MMP gene polymorphism and susceptibility to cervical cancer in Chinese women.
    Panminerva Med. 2017 Oct 9. doi: 10.23736/S0031-0808.17.03361.
    Abstract    



  86. PRASAD CB, Prasad SB, Yadav SS, Pandey LK, et al
    Olaparib modulates DNA repair efficiency, sensitizes cervical cancer cells to cisplatin and exhibits anti-metastatic property.
    Sci Rep. 2017;7:12876.
    Abstract    

    Abstract available

  87. ZHANG DL, Sun GX, Tian J, Zhang HX, et al
    Up-regulation of RIP3 alleviates cervical cancer progression through inducing necroptosis.
    Biochem Biophys Res Commun. 2017 Oct 6. pii: S0006-291X(17)31994.
    Abstract    

    Abstract available

  88. AKGUN O, Kahyaoglu M, Gecmen C, Kalayci Karabay A, et al
    Case Image: Cardiac metastasis of cervical cancer.
    Turk Kardiyol Dern Ars. 2017;45:675.
    Abstract    



  89. UPENDRAM P, Sahni S, Mohiuddin K, Poornima S, et al
    Amplification of specific chromosomal regions assessed by fluorescent in situ hybridization on Pap smears to be added as screening tool for identifying women at risk of progressing to cervical cancer.
    Tumour Biol. 2017;39:1010428317698363.
    Abstract    

    Abstract available

  90. LI H, Li M, Pang Y, Liu F, et al
    Fructose1,6bisphosphatase1 decrease may promote carcinogenesis and chemoresistance in cervical cancer.
    Mol Med Rep. 2017 Sep 29. doi: 10.3892/mmr.2017.7665.
    Abstract    

    Abstract available

  91. VANDERBILT DB, Ho QA, Goyal U, Bell RC, et al
    HPV-related nasopharyngeal and cervical cancer in a married couple in North America.
    Pract Radiat Oncol. 2017 Sep 8. pii: S1879-8500(17)30260.
    Abstract    



  92. ISLAM S, Mazumder Indra D, Basu M, Roychowdhury A, et al
    Phylogenetic analysis of Human papillomavirus 16 variants isolated from Indian Breast cancer patients showed difference in genetic diversity with that of cervical cancer isolates.
    Virus Res. 2017;243:1-9.
    Abstract    

    Abstract available

  93. FERRANDINA G, Distefano M, Mascilini F, Gallotta V, et al
    Could lymphadenectomy be avoided in locally advanced cervical cancer patients administered preoperative chemoradiation? A large-scale retrospective study.
    Eur J Surg Oncol. 2017 Sep 23. pii: S0748-7983(17)30703.
    Abstract    

    Abstract available

  94. BASU P, Mittal S, Bhadra Vale D, Chami Kharaji Y, et al
    Secondary prevention of cervical cancer.
    Best Pract Res Clin Obstet Gynaecol. 2017 Sep 6. pii: S1521-6934(17)30130.
    Abstract    

    Abstract available

  95. BARRE S, Massetti M, Leleu H, De Bels F, et al
    Organised screening for cervical cancer in France: a cost-effectiveness assessment.
    BMJ Open. 2017;7:e014626.
    Abstract    

    Abstract available

  96. SARANYA J, Dhanya BP, Greeshma G, Radhakrishnan KV, et al
    Effects of a new synthetic zerumbone pendant derivative (ZPD) on apoptosis induction and anti-migratory effects in human cervical cancer cells.
    Chem Biol Interact. 2017 Oct 4. pii: S0009-2797(17)30428.
    Abstract    

    Abstract available

  97. SMITH MA, Edwards S, Canfell K
    Impact of the National Cervical Screening Programme in New Zealand by age: analysis of cervical cancer trends 1985-2013 in all women and in Maori women.
    Cancer Causes Control. 2017 Oct 6. doi: 10.1007/s10552-017-0967.
    Abstract    

    Abstract available

  98. CHAIWONGKOT A, Niruthisard S, Kitkumthorn N, Bhattarakosol P, et al
    Quantitative methylation analysis of human papillomavirus 16L1 gene reveals potential biomarker for cervical cancer progression.
    Diagn Microbiol Infect Dis. 2017 Aug 25. pii: S0732-8893(17)30262.
    Abstract    

    Abstract available

  99. VARMUS H
    A Prize for Cancer Prevention.
    Cell. 2017;171:14-17.
    Abstract    

    Abstract available


  100. Two Basic Scientists Walk into a Translational Space.
    Cell. 2017;171:23-27.
    Abstract    

    Abstract available

  101. GUAN Y, Li W, Jiang Z, Zhang B, et al
    Value of whole-lesion apparent diffusion coefficient (ADC) first-order statistics and texture features in clinical staging of cervical cancers.
    Clin Radiol. 2017;72:951-958.
    Abstract    

    Abstract available

  102. WALKER H, Burrell M, Flatley J, Powers H, et al
    A metabolite profiling method for diagnosis of precancerous cervical lesions and HPV persistence.
    Bioanalysis. 2017;9:601-608.
    Abstract    

    Abstract available

  103. SHAPIRO GK, Perez S, Rosberger Z
    The authors respond to "Supporting the call for a gender-neutral human papillomavirus vaccination in Canada".
    CMAJ. 2017;189:E119.
    Abstract    



  104. PATEL C, Macartney K
    Supporting the call for a gender-neutral human papillomavirus vaccination in Canada.
    CMAJ. 2017;189:E118.
    Abstract    



  105. RA JC, Park SB, Lee JB, Han BH, et al
    Adenofibroma in the Uterine Cervix Manifesting as Multilocular Cystic Lesions.
    Ultrasound Q. 2017;33:74-76.
    Abstract    

    Abstract available

  106. ZHOU LL, Shen Y, Gong JM, Sun P, et al
    MicroRNA-466 with tumor markers for cervical cancer screening.
    Oncotarget. 2017;8:70821-70827.
    Abstract    

    Abstract available

  107. MENG F, Liu H, Liu S, Ma R, et al
    The clinical significance of HPIP and the associated prognosis in cervical cancer.
    Oncotarget. 2017;8:70262-70270.
    Abstract    

    Abstract available

  108. LIAO S, Xiao S, Chen H, Zhang M, et al
    The receptor for activated protein kinase C promotes cell growth, invasion and migration in cervical cancer.
    Int J Oncol. 2017 Sep 27. doi: 10.3892/ijo.2017.4137.
    Abstract    

    Abstract available

  109. HODGKINSON N, Kruger CA, Mokwena M, Abrahamse H, et al
    Cervical cancer cells (HeLa) response to photodynamic therapy using a zinc phthalocyanine photosensitizer.
    J Photochem Photobiol B. 2017;177:32-38.
    Abstract    

    Abstract available

  110. BOWEN SR, Yuh WTC, Hippe DS, Wu W, et al
    Tumor radiomic heterogeneity: Multiparametric functional imaging to characterize variability and predict response following cervical cancer radiation therapy.
    J Magn Reson Imaging. 2017 Oct 16. doi: 10.1002/jmri.25874.
    Abstract    

    Abstract available

  111. SHILPA G, Renjitha J, Saranga R, Sajin FK, et al
    Epoxyazadiradione Purified from the Azadirachta indica Seed Induced Mitochondrial Apoptosis and Inhibition of NFkappaB Nuclear Translocation in Human Cervical Cancer Cells.
    Phytother Res. 2017 Oct 18. doi: 10.1002/ptr.5932.
    Abstract    

    Abstract available

  112. XU T, Pang Q, Wang Y, Yan X, et al
    Betulinic acid induces apoptosis by regulating PI3K/Akt signaling and mitochondrial pathways in human cervical cancer cells.
    Int J Mol Med. 2017 Sep 28. doi: 10.3892/ijmm.2017.3163.
    Abstract    

    Abstract available

  113. CRISAN-VIDA M, Lupse OS, Stoicu-Tivadar L, Salvari D, et al
    Regional Monitoring of Cervical Cancer.
    Stud Health Technol Inform. 2017;244:28-32.
    Abstract    

    Abstract available

  114. LENOIR P, Moulahi B, Aze J, Bringay S, et al
    Raising Awareness About Cervical Cancer Using Twitter: Content Analysis of the 2015 #SmearForSmear Campaign.
    J Med Internet Res. 2017;19:e344.
    Abstract    

    Abstract available

  115. WEI L, Gan Q, Ji T
    Cervical cancer histology image identification method based on texture and lesion area features.
    Comput Assist Surg (Abingdon). 2017.
    Abstract    

    Abstract available

  116. WANYENZE RK, Bwanika JB, Beyeza-Kashesya J, Mugerwa S, et al
    Uptake and correlates of cervical cancer screening among HIV-infected women attending HIV care in Uganda.
    Glob Health Action. 2017;10:1380361.
    Abstract    

    Abstract available

  117. TERMRUNGRUANGLERT W, Khemapech N, Tantitamit T, Sangrajrang S, et al
    Cost-effectiveness analysis study of HPV testing as a primary cervical cancer screening in Thailand.
    Gynecol Oncol Rep. 2017;22:58-63.
    Abstract    

    Abstract available

  118. ROJAS P, Li T, Ravelo GJ, Dawson C, et al
    Correlates of Cervical Cancer Screening Among Adult Latino Women: A 5-Year Follow-Up.
    World Med Health Policy. 2017;9:239-254.
    Abstract    

    Abstract available

  119. AGGARWAL U, Goyal AK, Rath G
    Development In Drug Targeting And Delivery In Cervical Cancer.
    Curr Cancer Drug Targets. 2017 Oct 9. doi: 10.2174/1568009617666171009165105.
    Abstract    

    Abstract available

  120. BUDA A, Papadia A, Di Martino G, Imboden S, et al
    Real-Time Fluorescent Sentinel Lymph Node Mapping with ICG in Women with Previous Conization Undergoing Laparoscopic Surgery for Early Invasive Cervical Cancer: Comparison with Radiotracer +/- Blue Dye.
    J Minim Invasive Gynecol. 2017 Oct 12. pii: S1553-4650(17)31225.
    Abstract    

    Abstract available

  121. WU SG, Zhang WW, Sun JY, Li FY, et al
    Multimodal treatment including hysterectomy improves survival in patients with locally advanced cervical cancer: A population-based, propensity score-matched analysis.
    Int J Surg. 2017 Oct 12. pii: S1743-9191(17)31358.
    Abstract    

    Abstract available

  122. MOTTON S, Martinez A, Chantalat E
    [Robot-assisted laparoscopic radical trachelectomy for early stage cervical cancer (with video)].
    Gynecol Obstet Fertil Senol. 2017 Oct 10. pii: S2468-7189(17)30194.
    Abstract    



  123. LI P, Tan Y, Zhu LX, Zhou LN, et al
    Prognostic value of HPV DNA status in cervical cancer before treatment: a systematic review and meta-analysis.
    Oncotarget. 2017;8:66352-66359.
    Abstract    

    Abstract available

  124. SU PH, Hsu YW, Huang RL, Weng YC, et al
    Methylomics of nitroxidative stress on precancerous cells reveals DNA methylation alteration at the transition from in situ to invasive cervical cancer.
    Oncotarget. 2017;8:65281-65291.
    Abstract    

    Abstract available

  125. ZHU J, Shi H, Liu H, Wang X, et al
    Long non-coding RNA TUG1 promotes cervical cancer progression by regulating the miR-138-5p-SIRT1 axis.
    Oncotarget. 2017;8:65253-65264.
    Abstract    

    Abstract available

  126. CHANG YH, Yin F, Fan GF, Zhao M, et al
    Down-regulation of miR-329-3p is associated with worse prognosis in patients with cervical cancer.
    Eur Rev Med Pharmacol Sci. 2017;21:4045-4049.
    Abstract    

    Abstract available

  127. SHAH CA, Beck T, Liao JB, Giannakopoulos NV, et al
    Surgical and oncologic outcomes after robotic radical hysterectomy as compared to open radical hysterectomy in the treatment of early cervical cancer.
    J Gynecol Oncol. 2017;28:e82.
    Abstract    

    Abstract available

  128. KATANYOO K
    Comparing treatment outcomes of stage IIIB cervical cancer patients between those with and without lower third of vaginal invasion.
    J Gynecol Oncol. 2017;28:e79.
    Abstract    

    Abstract available

  129. JIANG W, Pan JJ, Deng YH, Liang MR, et al
    Down-regulated serum microRNA-101 is associated with aggressive progression and poor prognosis of cervical cancer.
    J Gynecol Oncol. 2017;28:e75.
    Abstract    

    Abstract available

  130. JAMAL A, Shahzadi L, Ahtzaz S, Zahid S, et al
    Identification of anti-cancer potential of doxazocin: Loading into chitosan based biodegradable hydrogels for on-site delivery to treat cervical cancer.
    Mater Sci Eng C Mater Biol Appl. 2018;82:102-109.
    Abstract    

    Abstract available

  131. MORRIS BJ, Hankins CA
    Effect of male circumcision on risk of sexually transmitted infections and cervical cancer in women.
    Lancet Glob Health. 2017;5:e1054-e1055.
    Abstract    



  132. KIM S, Hmielowski JD
    The Influence of Self-efficacy in Medical Drama Television Programming on Behaviors and Emotions that Promote Cervical Cancer Prevention.
    Am J Health Behav. 2017;41:719-727.
    Abstract    

    Abstract available

  133. CHO O, Chun M, Oh YT, Noh OK, et al
    Prognostic implication of simultaneous anemia and lymphopenia during concurrent chemoradiotherapy in cervical squamous cell carcinoma.
    Tumour Biol. 2017;39:1010428317733144.
    Abstract    

    Abstract available

  134. KAWAHARA H, Akiba T, Yanaga K
    Transanal Assisted Resection with Closure of Anal Canal for Lower Rectal Diseases.
    Anticancer Res. 2017;37:5767-5769.
    Abstract    

    Abstract available

  135. CUZICK J, Myers O, Lee JH, Shi Y, et al
    Outcomes in Women With Cytology Showing Atypical Squamous Cells of Undetermined Significance With vs Without Human Papillomavirus Testing.
    JAMA Oncol. 2017;3:1327-1334.
    Abstract    

    Abstract available

  136. VOGEL L
    HPV not just a young woman's problem.
    CMAJ. 2017;189:E416-E417.
    Abstract    



  137. DICKINSON JA, Ogilvie G, Van Niekerk D, Popadiuk C, et al
    Evidence that supports policies to delay cervical screening until after age 25 years.
    CMAJ. 2017;189:E380-E381.
    Abstract    



  138. COLLIER R
    Two-dose HPV regimen recommended in US.
    CMAJ. 2017;189:E36.
    Abstract    



  139. EDATT L, Maurya AK, Raji G, Kunhiraman H, et al
    MicroRNA106a regulates matrix metalloprotease 9 in a sirtuin-1 dependent mechanism.
    J Cell Physiol. 2018;233:238-248.
    Abstract    

    Abstract available

  140. CONSTANTINOU P, Tischkowitz M
    Genetics of gynaecological cancers.
    Best Pract Res Clin Obstet Gynaecol. 2017;42:114-124.
    Abstract    

    Abstract available

  141. WOESTENBERG PJ, King AJ, van der Sande MA, Donken R, et al
    No evidence for cross-protection of the HPV-16/18 vaccine against HPV-6/11 positivity in female STI clinic visitors.
    J Infect. 2017 Jan 23. pii: S0163-4453(17)30026.
    Abstract    

    Abstract available

  142. CASTANON A
    Cone depth increases risk of adverse obstetric outcomes following treatment for cervical preinvasive disease.
    Evid Based Med. 2017;22:37.
    Abstract    



  143. ALBERTO RR, Yudibeth SL, Jonathan FM, Raul FM, et al
    Design, Synthesis and Biological Evaluation of a Phenyl Butyric Acid Derivative, N-(4-chlorophenyl)-4-phenylbutanamide: A HDAC6 Inhibitor with Anti-proliferative Activity on Cervix Cancer and Leukemia Cells.
    Anticancer Agents Med Chem. 2017;17:1441-1454.
    Abstract    

    Abstract available

  144. ALLARD-VANNIER E, Herve-Aubert K, Kaaki K, Blondy T, et al
    Folic acid-capped PEGylated magnetic nanoparticles enter cancer cells mostly via clathrin-dependent endocytosis.
    Biochim Biophys Acta. 2017;1861:1578-1586.
    Abstract    

    Abstract available

  145. SHENOY S, Thapamagar S
    Amyotrophic dermatomyositis.
    CMAJ. 2017;189:E164.
    Abstract    



  146. QIAN S, Li M
    Chamaejasmine induces apoptosis in HeLa cells through the PI3K/Akt signaling pathway.
    Anticancer Drugs. 2017;28:40-50.
    Abstract    

    Abstract available

  147. LIU Y, Li L, Liu Y, Geng P, et al
    RECK inhibits cervical cancer cell migration and invasion by promoting p53 signaling pathway.
    J Cell Biochem. 2017 Oct 24. doi: 10.1002/jcb.26441.
    Abstract    

    Abstract available

  148. TRYBUS W, Krol T, Trybus E, Kopacz-Bednarska A, et al
    Changes in the Lysosomal System of Cervical Cancer Cells Induced by Emodin Action.
    Anticancer Res. 2017;37:6087-6096.
    Abstract    

    Abstract available

  149. DU XX, Yang H, Zhang HJ, Li LA, et al
    [Clinical study of intensity modulated radiotherapy and three-dimensional conformal radiotherapy with three-dimensional brachytherapy and concurrent chemotherapy for patients with advanced cervical cancer].
    Zhonghua Fu Chan Ke Za Zhi. 2017;52:679-686.
    Abstract    

    Abstract available

  150. MENDES D, Mesher D, Pista A, Baguelin M, et al
    Understanding differences in cervical cancer incidence in Western Europe: comparing Portugal and England.
    Eur J Public Health. 2017 Oct 20. doi: 10.1093.
    Abstract    

    Abstract available

  151. BOROMAND N, Hasanzadeh M, Sales SS, Farazestanian M, et al
    Clinical and Prognostic Value of the C-Met/HGF Signaling Pathway in Cervical Cancer.
    J Cell Physiol. 2017 Oct 23. doi: 10.1002/jcp.26232.
    Abstract    

    Abstract available

  152. ALI S, Skirton H, Clark MT, Donaldson C, et al
    Integrative review of cervical cancer screening in Western Asian and Middle Eastern Arab countries.
    Nurs Health Sci. 2017 Oct 23. doi: 10.1111/nhs.12374.
    Abstract    

    Abstract available

  153. WOO S, Kim SY, Cho JY, Kim SH, et al
    Apparent diffusion coefficient for prediction of parametrial invasion in cervical cancer: a critical evaluation based on stratification to a Likert scale using T2-weighted imaging.
    Radiol Med. 2017 Oct 20. doi: 10.1007/s11547-017-0823.
    Abstract    

    Abstract available

  154. PLACHTA M, Cholewinski W, Burchardt E, Cegla P, et al
    Strategy and early results of treatment of advanced cervical cancer patients with synchronous cancers observed in PET-CT imaging.
    Ginekol Pol. 2017;88:475-480.
    Abstract    

    Abstract available

  155. SCHIFFMAN M, Wentzensen N
    Effective use of human papillomavirus testing for cervical cancer screening requires extended intervals to target persistent infections and precancerous lesions.
    Prev Med. 2017;105:378-380.
    Abstract    

    Abstract available

  156. ALMASI-HASHIANI A, Ayubi E, Safiri S
    Risk of metachronous ovarian cancer after ovarian conservation in young women with stage I cervical cancer: Methodological issues.
    Am J Obstet Gynecol. 2017 Oct 17. pii: S0002-9378(17)31203.
    Abstract    



  157. NARAYANAN P, Sahdev A
    The role of 18F-FDG PET CT in Common Gynaecological Malignancies.
    Br J Radiol. 2017 Aug 22:20170283. doi: 10.1259/bjr.20170283.
    Abstract    

    Abstract available

  158. WALLACE NA, Khanal S, Robinson KL, Wendel SO, et al
    High-Risk Alphapapillomavirus Oncogenes Impair the Homologous Recombination Pathway.
    J Virol. 2017;91.
    Abstract    

    Abstract available

  159. PAOLINI F, Curzio G, Cordeiro MN, Massa S, et al
    HPV 16 E5 oncoprotein is expressed in early stage carcinogenesis and can be a target of immunotherapy.
    Hum Vaccin Immunother. 2017;13:291-297.
    Abstract    

    Abstract available

  160. HASS R, Jacobs R, Kaufmann AM, Hillemanns P, et al
    Sensitization of immune cells following hexylaminolevulinate photodynamic therapy of cervical intraepithelial neoplasia.
    Photodiagnosis Photodyn Ther. 2017;17:82-86.
    Abstract    

    Abstract available

  161. DANIEL A, P A, Ganesan S, Joseph L, et al
    Biochemical assessment of human uterine cervix by micro-Raman mapping.
    Photodiagnosis Photodyn Ther. 2017;17:65-74.
    Abstract    

    Abstract available

  162. YIN G, Li J, Wu A, Liang J, et al
    Four categories of LEEP for CIN of various areas: a retrospective cohort study.
    Minim Invasive Ther Allied Technol. 2017;26:104-110.
    Abstract    

    Abstract available

  163. VISTAD I, Bjorge L, Solheim O, Fiane B, et al
    A national, prospective observational study of first recurrence after primary treatment for gynecological cancer in Norway.
    Acta Obstet Gynecol Scand. 2017 Aug 10. doi: 10.1111/aogs.13199.
    Abstract    

    Abstract available

  164. WILSON LF, Pandeya N, Mishra GD
    Hysterectomy trends in Australia, 2000-01 to 2013-14: Joinpoint regression analysis.
    Acta Obstet Gynecol Scand. 2017 Jun 19. doi: 10.1111/aogs.13182.
    Abstract    

    Abstract available

  165. PRINJA S, Bahuguna P, Faujdar DS, Jyani G, et al
    Cost-effectiveness of human papillomavirus vaccination for adolescent girls in Punjab state: Implications for India's universal immunization program.
    Cancer. 2017;123:3253-3260.
    Abstract    

    Abstract available

  166. CHAD-FRIEDMAN E, Coleman S, Traeger LN, Pirl WF, et al
    Psychological distress associated with cancer screening: A systematic review.
    Cancer. 2017;123:3882-3894.
    Abstract    

    Abstract available

  167. NELSON RA, Lai LL
    Elevated risk of human papillomavirus-related second cancers in survivors of anal canal cancer.
    Cancer. 2017;123:4013-4021.
    Abstract    

    Abstract available

  168. TRACHT JM, Davis AD, Fasciano DN, Eltoum IA, et al
    Discrepant HPV/cytology cotesting results: Are there differences between cytology-negative versus HPV-negative cervical intraepithelial neoplasia?
    Cancer. 2017 Aug 17. doi: 10.1002/cncy.21905.
    Abstract    

    Abstract available

  169. GRANADOS R, Tellez-Safina H, Solis I, Mateos F, et al
    Cervical cancer screening cotesting with cytology and MRNA HPV E6/E7 yields high rates of CIN2+ lesions in young women.
    Diagn Cytopathol. 2017 Sep 26. doi: 10.1002/dc.23821.
    Abstract    

    Abstract available

  170. YANG J, Nolte FS, Chajewski OS, Lindsey KG, et al
    Cytology and high risk HPV testing in cervical cancer screening program: Outcome of 3-year follow-up in an academic institute.
    Diagn Cytopathol. 2017 Oct 19. doi: 10.1002/dc.23843.
    Abstract    

    Abstract available

  171. KIM HJ, Kim CY, Jin J, Bae MK, et al
    Aberrant single-minded homolog 1 methylation as a potential biomarker for cervical cancer.
    Diagn Cytopathol. 2017 Oct 24. doi: 10.1002/dc.23838.
    Abstract    

    Abstract available

  172. MACDONALD MC, Brown BH, Lyon RE, Healey TJ, et al
    Influence of high risk HPV genotype on colposcopic performance: A large prospective study demonstrates improved detection of disease with ZedScan I, particularly in non-HPV 16 patients.
    Eur J Obstet Gynecol Reprod Biol. 2017;211:194-198.
    Abstract    

    Abstract available

  173. DONAIRE C, Reillo M, Martinez-Escoriza JC, Lopez-Fernandez JA, et al
    Anal study in immunocompetent women with human papillomavirus related lower genital tract pathology.
    Eur J Obstet Gynecol Reprod Biol. 2017;211:15-20.
    Abstract    

    Abstract available

  174. MAKKONEN P, Heinavaara S, Sarkeala T, Anttila A, et al
    Impact of organized and opportunistic Pap testing on the risk of cervical cancer in young women - A case-control study from Finland.
    Gynecol Oncol. 2017 Sep 21. pii: S0090-8258(17)31335.
    Abstract    

    Abstract available

  175. LEE SW, Lee SH, Kim J, Kim YS, et al
    Magnetic resonance imaging during definitive chemoradiotherapy can predict tumor recurrence and patient survival in locally advanced cervical cancer: A multi-institutional retrospective analysis of KROG 16-01.
    Gynecol Oncol. 2017 Sep 18. pii: S0090-8258(17)31265.
    Abstract    

    Abstract available

  176. QIAN Y, Pollom EL, Nwachukwu C, Seiger K, et al
    Extent of lymphovascular space invasion may predict lymph node metastasis in uterine serous carcinoma.
    Gynecol Oncol. 2017 Jul 11. pii: S0090-8258(17)31137.
    Abstract    

    Abstract available

  177. YAMAMOTO K, Nagao S, Suzuki K, Kogiku A, et al
    Pelvic fractures after definitive and postoperative radiotherapy for cervical cancer: A retrospective analysis of risk factors.
    Gynecol Oncol. 2017 Oct 18. pii: S0090-8258(17)31359.
    Abstract    

    Abstract available

  178. CAO L, Sun PL, Yao M, Chen S, et al
    Clinical significance of CK7, HPV-L1, and koilocytosis for patients with cervical low-grade squamous intraepithelial lesions: a retrospective analysis.
    Hum Pathol. 2017;65:194-200.
    Abstract    

    Abstract available

  179. ZHANG Y, Xia P, Zhang W, Yan M, et al
    Short interfering RNA targeting Net1 reduces the angiogenesis and tumor growth of in vivo cervical squamous cell carcinoma through VEGF down-regulation.
    Hum Pathol. 2017;65:113-122.
    Abstract    

    Abstract available

  180. LIU Y, Alqatari M, Sultan K, Ye F, et al
    Using p16 immunohistochemistry to classify morphologic cervical intraepithelial neoplasia 2: correlation of ambiguous staining patterns with HPV subtypes and clinical outcome.
    Hum Pathol. 2017;66:144-151.
    Abstract    

    Abstract available

  181. GIANNICO GA, Gown AM, Epstein JI, Revetta F, et al
    Role of SATB2 in distinguishing the site of origin in glandular lesions of the bladder/urinary tract.
    Hum Pathol. 2017;67:152-159.
    Abstract    

    Abstract available

  182. PAN R, Zhu M, Yu C, Lv J, et al
    Cancer incidence and mortality: A cohort study in China, 2008-2013.
    Int J Cancer. 2017;141:1315-1323.
    Abstract    

    Abstract available

  183. MATSUO K, Shimada M, Yamaguchi S, Kanao H, et al
    Identifying a candidate population for ovarian conservation in young women with clinical stage IB-IIB cervical cancer.
    Int J Cancer. 2017 Oct 4. doi: 10.1002/ijc.31084.
    Abstract    

    Abstract available

  184. ZHANG Q, Dong L, Hu S, Feng R, et al
    Risk stratification and long-term risk prediction of E6 oncoprotein in a prospective screening cohort in China.
    Int J Cancer. 2017;141:1110-1119.
    Abstract    

    Abstract available

  185. BROTHERTON JM, Tabrizi SN, Phillips S, Pyman J, et al
    Looking beyond human papillomavirus (HPV) genotype 16 and 18: Defining HPV genotype distribution in cervical cancers in Australia prior to vaccination.
    Int J Cancer. 2017 Jul 5. doi: 10.1002/ijc.30871.
    Abstract    

    Abstract available

  186. VELDHUIJZEN NJ, Polman NJ, Snijders PJF, Meijer CJLM, et al
    Stratifying HPV-positive women for CIN3+ risk after one and two rounds of HPV-based screening.
    Int J Cancer. 2017 Jul 3. doi: 10.1002/ijc.30865.
    Abstract    

    Abstract available

  187. AGORASTOS T, Chatzistamatiou K, Moysiadis T, Kaufmann AM, et al
    Human papillomavirus E7 protein detection as a method of triage to colposcopy of HPV positive women, in comparison to genotyping and cytology. Final results of the PIPAVIR study.
    Int J Cancer. 2017 May 3. doi: 10.1002/ijc.30761.
    Abstract    



  188. SHEN C, Liu Y, Shi S, Zhang R, et al
    Long-distance interaction of the integrated HPV fragment with MYC gene and 8q24.22 region up-regulating the allele-specific MYC expression in HeLa cells.
    Int J Cancer. 2017 May 3. doi: 10.1002/ijc.30763.
    Abstract    

    Abstract available

  189. MATSUZAKI S, Serada S, Hiramatsu K, Nojima S, et al
    Anti-glypican-1 antibody-drug conjugate exhibits potent preclinical antitumor activity against glypican-1 positive uterine cervical cancer.
    Int J Cancer. 2017 Oct 21. doi: 10.1002/ijc.31124.
    Abstract    

    Abstract available

  190. CASTLE PE, Murokora D, Perez C, Alvarez M, et al
    Treatment of cervical intraepithelial lesions.
    Int J Gynaecol Obstet. 2017;138 Suppl 1:20-25.
    Abstract    

    Abstract available

  191. LAMONTAGNE DS, Bloem PJN, Brotherton JML, Gallagher KE, et al
    Progress in HPV vaccination in low- and lower-middle-income countries.
    Int J Gynaecol Obstet. 2017;138 Suppl 1:7-14.
    Abstract    

    Abstract available

  192. CHIGBU CO, Onyebuchi AK, Onyeka TC, Odugu BU, et al
    The impact of community health educators on uptake of cervical and breast cancer prevention services in Nigeria.
    Int J Gynaecol Obstet. 2017;137:319-324.
    Abstract    

    Abstract available

  193. WEI WF, Han LF, Liu D, Wu LF, et al
    Orthotopic Xenograft Mouse Model of Cervical Cancer for Studying the Role of MicroRNA-21 in Promoting Lymph Node Metastasis.
    Int J Gynecol Cancer. 2017;27:1587-1595.
    Abstract    

    Abstract available

  194. HILLESHEIM I, Limone GA, Klimann L, Monego H, et al
    Cervical Cancer Posttreatment Follow-up: Critical Analysis.
    Int J Gynecol Cancer. 2017;27:1747-1752.
    Abstract    

    Abstract available

  195. TAKIUCHI T, Machida H, Hom MS, Mostofizadeh S, et al
    Association of Metformin Use and Survival Outcome in Women With Cervical Cancer.
    Int J Gynecol Cancer. 2017;27:1455-1463.
    Abstract    

    Abstract available

  196. KIYOTOKI T, Nakamura K, Haraga J, Omichi C, et al
    Sarcopenia Is an Important Prognostic Factor in Patients With Cervical Cancer Undergoing Concurrent Chemoradiotherapy.
    Int J Gynecol Cancer. 2017 Oct 17. doi: 10.1097/IGC.0000000000001127.
    Abstract    

    Abstract available

  197. JIANG Y, Ren W, Wang W, Xia J, et al
    Inhibitor of beta-catenin and TCF (ICAT) promotes cervical cancer growth and metastasis by disrupting E-cadherin/beta-catenin complex.
    Oncol Rep. 2017 Sep 18. doi: 10.3892/or.2017.5962.
    Abstract    

    Abstract available

  198. WANG Z, He S, Guo P, Guo X, et al
    MicroRNA-1297 inhibits metastasis and epithelial-mesenchymal transition by targeting AEG-1 in cervical cancer.
    Oncol Rep. 2017 Sep 20. doi: 10.3892/or.2017.5979.
    Abstract    

    Abstract available

  199. EOH KJ, Paek J, Kim SW, Kim HJ, et al
    Long non-coding RNA, steroid receptor RNA activator (SRA), induces tumor proliferation and invasion through the NOTCH pathway in cervical cancer cell lines.
    Oncol Rep. 2017 Oct 11. doi: 10.3892/or.2017.6023.
    Abstract    

    Abstract available

  200. NOVAKOVA E, Heijkoop ST, Quint S, Zolnay AG, et al
    What is the optimal number of library plans in ART for locally advanced cervical cancer?
    Radiother Oncol. 2017 Sep 19. pii: S0167-8140(17)32557.
    Abstract    

    Abstract available

  201. ANDREYCHENKO A, Kroon PS, Maspero M, Jurgenliemk-Schulz I, et al
    The feasibility of semi-automatically generated red bone marrow segmentations based on MR-only for patients with gynecologic cancer.
    Radiother Oncol. 2017;123:164-168.
    Abstract    

    Abstract available

  202. SHACK L, Lu S, Weeks LA, Craighead P, et al
    Determining the need and utilization of radiotherapy in cancers of the breast, cervix, lung, prostate and rectum: A population level study.
    Radiother Oncol. 2017;122:152-158.
    Abstract    

    Abstract available

  203. PARK S, Eom K, Kim J, Bang H, et al
    MiR-9, miR-21, and miR-155 as potential biomarkers for HPV positive and negative cervical cancer.
    BMC Cancer. 2017;17:658.
    Abstract    

    Abstract available

  204. STUQUI B, Conceicao AL, Termini L, Sichero L, et al
    The differential role of HTRA1 in HPV-positive and HPV-negative cervical cell line proliferation.
    BMC Cancer. 2016;16:840.
    Abstract    

    Abstract available

  205. WOODHEAD C, Cunningham R, Ashworth M, Barley E, et al
    Cervical and breast cancer screening uptake among women with serious mental illness: a data linkage study.
    BMC Cancer. 2016;16:819.
    Abstract    

    Abstract available

  206. HE S, Liao B, Deng Y, Su C, et al
    MiR-216b inhibits cell proliferation by targeting FOXM1 in cervical cancer cells and is associated with better prognosis.
    BMC Cancer. 2017;17:673.
    Abstract    

    Abstract available

  207. THARAVICHITKUL E, Lorvidhaya V, Kamnerdsupaphon P, Sukthomya V, et al
    Combined chemoradiation of cisplatin versus carboplatin in cervical carcinoma: a single institution experience from Thailand.
    BMC Cancer. 2016;16:501.
    Abstract    

    Abstract available

  208. LI L, Song X, Liu R, Li N, et al
    Chemotherapy versus radiotherapy for FIGO stages IB1 and IIA1 cervical carcinoma patients with postoperative isolated deep stromal invasion: a retrospective study.
    BMC Cancer. 2016;16:403.
    Abstract    

    Abstract available

  209. VOJTECHOVA Z, Sabol I, Salakova M, Smahelova J, et al
    Comparison of the miRNA profiles in HPV-positive and HPV-negative tonsillar tumors and a model system of human keratinocyte clones.
    BMC Cancer. 2016;16:382.
    Abstract    

    Abstract available

  210. CANFELL K, Caruana M, Gebski V, Darlington-Brown J, et al
    Cervical screening with primary HPV testing or cytology in a population of women in which those aged 33 years or younger had previously been offered HPV vaccination: Results of the Compass pilot randomised trial.
    PLoS Med. 2017;14:e1002388.
    Abstract    

    Abstract available

  211. SLOTTA C, Schluter T, Ruiz-Perera LM, Kadhim HM, et al
    CRISPR/Cas9-mediated knockout of c-REL in HeLa cells results in profound defects of the cell cycle.
    PLoS One. 2017;12:e0182373.
    Abstract    

    Abstract available

  212. XI J, Chen J, Xu M, Yang H, et al
    Genetic variability and functional implication of the long control region in HPV-16 variants in Southwest China.
    PLoS One. 2017;12:e0182388.
    Abstract    

    Abstract available

  213. SABOL I, Milutin Gasperov N, Matovina M, Bozinovic K, et al
    Cervical HPV type-specific pre-vaccination prevalence and age distribution in Croatia.
    PLoS One. 2017;12:e0180480.
    Abstract    

    Abstract available

  214. YANEZ RJR, Lamprecht R, Granadillo M, Weber B, et al
    Expression optimization of a cell membrane-penetrating human papillomavirus type 16 therapeutic vaccine candidate in Nicotiana benthamiana.
    PLoS One. 2017;12:e0183177.
    Abstract    

    Abstract available

  215. ZHANG L, Xie F, Wang X, Peng D, et al
    Previous cervical cytology and high-risk human papillomavirus testing in a cohort of patients with invasive cervical carcinoma in Shandong Province, China.
    PLoS One. 2017;12:e0180618.
    Abstract    

    Abstract available

  216. MCGRATH CJ, Garcia R, Trinh TT, Richardson BA, et al
    Role of p16 testing in cervical cancer screening among HIV-infected women.
    PLoS One. 2017;12:e0185597.
    Abstract    

    Abstract available

  217. BINKA C, Doku DT, Awusabo-Asare K
    Experiences of cervical cancer patients in rural Ghana: An exploratory study.
    PLoS One. 2017;12:e0185829.
    Abstract    

    Abstract available

  218. UEDA A, Takasawa A, Akimoto T, Takasawa K, et al
    Prognostic significance of the co-expression of EGFR and HER2 in adenocarcinoma of the uterine cervix.
    PLoS One. 2017;12:e0184123.
    Abstract    

    Abstract available

  219. BOTWRIGHT S, Holroyd T, Nanda S, Bloem P, et al
    Experiences of operational costs of HPV vaccine delivery strategies in Gavi-supported demonstration projects.
    PLoS One. 2017;12:e0182663.
    Abstract    

    Abstract available

  220. STANISAVLJEVIC D, Petrovic I, Vukovic V, Schwirtlich M, et al
    SOX14 activates the p53 signaling pathway and induces apoptosis in a cervical carcinoma cell line.
    PLoS One. 2017;12:e0184686.
    Abstract    

    Abstract available

  221. KWAK YK, Lee SW, Kay CS, Park HH, et al
    Intensity-modulated radiotherapy reduces gastrointestinal toxicity in pelvic radiation therapy with moderate dose.
    PLoS One. 2017;12:e0183339.
    Abstract    

    Abstract available

  222. HU X, Li S, Zhou L, Zhao M, et al
    Effect of vitamin E supplementation on uterine cervical neoplasm: A meta-analysis of case-control studies.
    PLoS One. 2017;12:e0183395.
    Abstract    

    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design:


;